Daniel Wilkinson (@dswilkinsonphd) 's Twitter Profile
Daniel Wilkinson

@dswilkinsonphd

Postdoc in the Fecci Lab by day…and also by night. Developing novel T cell-based therapeutics for GBM as a part of the Duke Brain Tumor Immunotherapy Program.

ID: 1523113310576553984

calendar_today08-05-2022 01:31:46

5 Tweet

35 Followers

90 Following

Nature Rev Immunol (@natrevimmunol) 's Twitter Profile Photo
Nature Rev Immunol
@natrevimmunol

3 years ago

Adaptive meets innate: CD8+ T cells kill MHC-I-negative tumour cells dlvr.it/Slfy7g

Bryan D. Choi MD PhD (@bryandchoi) 's Twitter Profile Photo
Bryan D. Choi MD PhD
@bryandchoi

3 years ago

Extraordinary clinical responses to CAR T cell therapy for solid tumors (heavily pretreated neuroblastoma) published in NEJM from investigators in Italy! nejm.org/doi/full/10.10…

Daniel Wilkinson (@dswilkinsonphd) 's Twitter Profile Photo
Daniel Wilkinson
@dswilkinsonphd

2 years ago

Really interesting and exciting stuff!

Immunology Podcast (@immunopodcast) 's Twitter Profile Photo
Immunology Podcast
@immunopodcast

2 years ago

📣 Check out our latest episode! Dr. Peter Fecci from Duke Center for Brain and Spine Metastasis talks about activating #Tcells to target brain tumors and his team’s work on targeting MHC-I-negative tumor cells. Listen now: bit.ly/3ts9E5W

Daniel Wilkinson (@dswilkinsonphd) 's Twitter Profile Photo
Daniel Wilkinson
@dswilkinsonphd

2 years ago

Honored and excited to have work from our group and led by Emily Lerner included in this collection!